This inventor holds 2 USPTO granted patents. Top assignee: Dracen Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Stuart R. Gallant
Introduction
Stuart R. Gallant is an accomplished inventor based in Belmont, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical applications. His work is characterized by a focus on improving drug delivery methods and enhancing therapeutic efficacy.
Latest Patents
Stuart R. Gallant holds a patent for a lyophilized composition comprising (S)-isopropyl 2-((S)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for subcutaneous administration. This patent outlines the formulation and use of lyophilates designed for subcutaneous administration to subjects, along with various pharmaceutical compositions and formulations.
Career Highlights
Stuart is currently associated with Dracen Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulations that can lead to better patient outcomes.
Collaborations
Throughout his career, Stuart has collaborated with notable professionals in the field, including Steven Dykstra and Gary Elliot. These collaborations have fostered a productive environment for innovation and development in pharmaceutical sciences.
Conclusion
Stuart R. Gallant's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic solutions.